The new mammographic screening guidelines: What were they thinking?

Obstetrics and Gynecology

Volumn 115, Issue 3, 2010, Pages 484-486

  Gemignani, Mary L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; BREAST EXAMINATION; CANCER PREVENTION; CANCER SCREENING; EDITORIAL; GROUPS BY AGE; HUMAN; MAMMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES;

AGED; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PREVENTIVE HEALTH SERVICES; RISK REDUCTION BEHAVIOR; UNITED STATES;

EID: 77649104524     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181d419ee     Document Type: Editorial

References (9)

1. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:716-726, W-236.
2. United States Department of Health and Human Services. Available at: www.hhs.gov. Retrieved January 12, 2010.
3. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137: 347-360 (Pubitemid 34977137)
4. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151:727-737, W237-42.
5. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009;151:738-747
6. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al, editors. SEER cancer statistics review, 1975-2002. Bethesda (MD): National Cancer Institute; 2006.
7. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353: 1784-1792
8. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90: 1371-1388
9. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358-366